Bryant PA, Trinder J, Curtis N. Sick and tired: does sleep have a vital role in the immune system? Nat Rev Immunol. 2004;4(6):457–67.
Dolgin E. Deprivation: a wake-up call. Nature. 2013;497(7450):S6–7.
Hanlon EC, Van Cauter E. Quantification of sleep behavior and of its impact on the cross-talk between the brain and peripheral metabolism. Proc Natl Acad Sci U S A. 2011;108 Suppl 3:15609–16.
Xie L et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373–7.
Anderson KN, Bradley AJ. Sleep disturbance in mental health problems and neurodegenerative disease. Nat Sci Sleep. 2013;5:61–75.
Monti JM et al. Sleep and circadian rhythm dysregulation in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2013;43:209–16.
Zanini M et al. Do sleep abnormalities and misaligned sleep/circadian rhythm patterns represent early clinical characteristics for developing psychosis in high risk populations? Neurosci Biobehav Rev. 2013;37(10 Pt 2):2631–7.
Benson KL. Sleep in schizophrenia. Sleep Med Clin. 2008;3:251–60.
Chouinard S et al. Sleep in untreated patients with schizophrenia: a meta-analysis. Schizophr Bull. 2004;30(4):957–67.
Poulin J et al. Sleep habits in middle-aged, non-hospitalized men and women with schizophrenia: a comparison with healthy controls. Psychiatry Res. 2010;179(3):274–8.
Brissos S et al. Satisfaction with life of schizophrenia outpatients and their caregivers: differences between patients with and without self-reported sleep complaints. Schizophr Res Treat. 2013;2013:502172.
Xiang YT et al. Prevalence and correlates of insomnia and its impact on quality of life in Chinese schizophrenia patients. Sleep. 2009;32(1):105–9.
Afonso P et al. Schizophrenia patients with predominantly positive symptoms have more disturbed sleep-wake cycles measured by actigraphy. Psychiatry Res. 2011;189(1):62–6.
Appelberg B, Katila H, Rimon R. Plasma interleukin-1 beta and sleep architecture in schizophrenia and other nonaffective psychoses. Psychosom Med. 1997;59(5):529–32.
Bromundt V et al. Sleep-wake cycles and cognitive functioning in schizophrenia. Br J Psychiatry. 2011;198(4):269–76.
Goder R, et al. Impairment of sleep-related memory consolidation in schizophrenia: relevance of sleep spindles? Sleep Med. 2015.
Manoach DS et al. A failure of sleep-dependent procedural learning in chronic, medicated schizophrenia. Biol Psychiatry. 2004;56(12):951–6.
Seeck-Hirschner M et al. Effects of daytime naps on procedural and declarative memory in patients with schizophrenia. J Psychiatr Res. 2010;44(1):42–7.
Wamsley EJ et al. Reduced sleep spindles and spindle coherence in schizophrenia: mechanisms of impaired memory consolidation? Biol Psychiatry. 2012;71(2):154–61.
Babkoff H et al. Perceptual distortions and hallucinations reported during the course of sleep deprivation. Percept Mot Skills. 1989;68(3 Pt 1):787–98.
West LJ et al. The psychosis of sleep deprivation. Ann N Y Acad Sci. 1962;96:66–70.
Brown LK. Can sleep deprivation studies explain why human adults sleep? Curr Opin Pulm Med. 2012;18(6):541–5.
Horne JA. Human sleep, sleep loss and behaviour. Implications for the prefrontal cortex and psychiatric disorder. Br J Psychiatry. 1993;162:413–9.
Killgore WD. Effects of sleep deprivation on cognition. Prog Brain Res. 2010;185:105–29.
Thomas M et al. Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity. J Sleep Res. 2000;9(4):335–52.
De Havas JA et al. Sleep deprivation reduces default mode network connectivity and anti-correlation during rest and task performance. Neuroimage. 2012;59(2):1745–51.
Mullington JM et al. Sleep loss and inflammation. Best Pract Res Clin Endocrinol Metab. 2010;24(5):775–84.
Goh VH et al. Effects of one night of sleep deprivation on hormone profiles and performance efficiency. Mil Med. 2001;166(5):427–31.25.
Czeisler CA. Impact of sleepiness and sleep deficiency on public health—utility of biomarkers. J Clin Sleep Med. 2011;7(5 Suppl):S6–8.
Mitchell AJ et al. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders—a systematic review and meta-analysis. Schizophr Bull. 2013;39(2):306–18.
Soehner A, Kaplan K, Harvey A. Insomnia comorbid to severe psychiatric illness. Sleep Med Clin. 2013;8(3):361–71.
Spiegelhalder K, Regen W, Nanovska S, Baglioni C, Riemann D. Comorbid sleep disorders in neuropsychiatric disorders across the life cycle. Curr Psychiatry Rep. 2013;15(6):364.
Baandrup L, Jennum P, Lublin H, Glenthoj B. Treatment options for residual insomnia in schizophrenia. Acta Psychiatr Scand. 2013;127(1):81–2.
Horn W, Akerman S, Sateia M. Sleep in schizophrenia and substance use disorders: a review of the literature. J Dual Diagn. 2013;9(3):228–38.
Kalucy M, Grunstein R, Lambert T, Glozier N. Obstructive sleep apnoea and schizophrenia—a research agenda. Sleep Med Rev. 2013;17(5):357–65.
Siebern AT, Manber R. New developments in cognitive behavioral therapy as the first-line treatment of insomnia. Psychol Res Behav Manag. 2011; 4.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.
Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504.
Palmese LB, DeGeorge PC, Ratliff JC, Srihari VH, Wexler BE, Krystal AD, et al. Insomnia is frequent in schizophrenia and associated with night eating and obesity. Schizophr Res. 2011;133(1–3):238–43.
Freeman D, Pugh K, Vorontsova N, Southgate L. Insomnia and paranoia. Schizophr Res. 2009;108(1–3):280–4.
Morgenthaler T et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. Sleep. 2006;29(11):1415–9.
Tek C et al. The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial. Schizophr Res. 2014;160(1-3):180–5. This double-blind, randomized placebo-controlled trial was the first to report the efficacy of eszopiclone on sleep in cognition in people with both schizophrenia and insomnia, finding a possible beneficial short-term effect on working memory.
Wamsley E et al. The effects of eszopiclone on sleep spindles and memory consolidation in schizophrenia: a randomized placebo-controlled trial. Sleep. 2013;36(9):1369–76. This double-blind, randomized placebo-controlled trial demonstrated that eszopiclone selectively enhances sleep spindle activity and supported the association between spindle activity and memory processing.
Andrade C, Suresh Kumar PN. Treating residual insomnia in schizophrenia: examining the options. Acta Psychiatr Scand. 2013;127(1):11.
Dixon L et al. The 2009 PORT psychosocial treatment recommendations and summary statement. Schizophr Bull. 2010;36(1):48–70.
Myers E, Startup H, Freeman D. Cognitive behavioural treatment of insomnia in individuals with persistent persecutory delusions: a pilot trial. J Behav Ther Exp Psychiatry. 2011;42:330–6.
Dopke C, Lehner R, Wells A. Cognitive-behavioral group therapy for insomnia in individuals with serious mental illnesses: a preliminary evaluation. Psychiatr Rehabil J. 2004;27(3):235–42.
Buysse DJ, Ancoli-Israel S, Edinger JD, Lichstein KL, Morin CM. Recommendations for a standard research assessment of insomnia. Sleep. 2006;29(9):1155–73.
Freeman D, Startup H, Myers E, Harvey A, Geddes J, Yu LM, et al. The effects of using cognitive behavioural therapy to improve sleep for patients with delusions and hallucinations (the BEST study): study protocol for a randomized controlled trial. Trials. 2013;14:214.
Epstein LJ et al. Clinical guideline for the evaluation, management, and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5(3):263–76.
Navqi H, Wang D, Glozier N, Grunstein R. Sleep-disordered breathing and psychiatric disorders. Curr Psychiatry Rep. 2014;16(12):519.
Winkelman J. Schizophrenia, obesity, and obstructive sleep apnea. J Clin Psychiatry. 2001;62:8–11.
Rishi MA, Shetty M, Wolff A, Amoateng-Adjepong Y, Manthous CA. Atypical antipsychotic medications are independently associated with severe obstructive sleep apnea. Clin Neuropharmacol. 2010;33:109–13.
Boufidis S, Kosmidis M, Bozikas V, Daskalopoulou-Vlahoyianni E, Pitsavas S, Karavatos A. Treatment outcome of obstructive sleep apnea syndrome in a patient with schizophrenia: Case report. Int J Psychiatry Med. 2003;33(3):305–10.
Karanti A, Landén M. Treatment refractory psychosis remitted upon treatment with continuous positive airway pressure: a case report. Psychopharmacol Bull. 2007;40(1):113–7.
Allison DB et al. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am J Prev Med. 2009;36(4):341–50.
Leinum C, Dopp J, Morgan B. Sleep-disordered breathing and obesity: pathophysiology, complications, and treatment. Nutr Clin Pract. 2009;24(6):675–87.
Morgenthaler T et al. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. Sleep. 2007;30(11):1445–59.
Wulff K, Dijk D, Middleton B, Foster R, Joyce E. Sleep and circadian rhythm disruption in schizophrenia. Br J Psychiatry. 2012;200(4):308–16.
Frank E, Swartz HA, Boland E. Interpersonal and social rhythm therapy: an intervention addressing rhythm dysregulation in bipolar disorder. Dialogues Clin Neurosci. 2007;9(3):325–32.
Kushida CA. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep. 2005;28(4):499–521.
Walters AS. Toward a better definition of the restless legs syndrome The International Restless Legs Syndrome Study Group. Mov Disord. 1995;10(5):634–42.
Allen RP et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101–19.
Kang S et al. Characteristics and clinical correlates of restless legs syndrome in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(5):1078–83.
Allen RP, Barker PB, Horska A, Earley CJ. Thalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleep. Neurology. 2013;80(22):2028–34. This neuroimaging study demonstrated a strong relation between Glx/Cr and wake time during sleep period, and total PSG and subjective sleep time during sleep period, but no relation with periodic limb movements per hour. These results provide some evidence for the glutamatergic system involvement in RLS and suggest that drugs targeting the glutamatergic system may be effective for sleep loss in RLS.
Oertel WH et al. Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study. Sleep Med. 2010;11:848–56.
Harvey AG, Murray G, Chandler RA, Soehner A. Sleep disturbance as transdiagnostic: consideration of neurobiological mechanisms. Clin Psychol Rev. 2011;31(2):225–35.
Kantrowitz J, Citrome L, Javitt D. GABAB receptors, schizophrenia and sleep dysfunction: a review of the relationship and its potential clinical and therapeutic implications. CNS Drugs. 2009;23(8):681–91.
Peacey J, Miller H, Huthwaite M, Romans S. Sleep medication in acute psychiatric illness: patient's knowledge and prescription patterns in New Zealand. J Nerv Ment Dis. 2012;200(1):83–7.
Huthwaite M, Miller H, McCartney J, Romans S. Dysfunctional cognitions about sleep in psychiatric patients. J Psychiatr Pract. 2014;20(3):188–95.
Klingaman EA. CBT-I for Veterans with Psychosis. Poster presented at: The 2015 Penn Sleep-Chronobiology Research Retreat; 2015; Philadelphia, PA.
Klingaman EA, et al. Consumer satisfaction with psychiatric services: The role of shared decision making and the therapeutic relationship. Psychiatr Rehabil J. 2015. [Epub ahead of print].
Park S, Derman M, Kreyenbuhl J, et al. Factors associated with shared decision-making preferences among veterans with serious mental illness. Psychiatr Serv. 2014;65(12):1409–13.